The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …

BACKGROUND The effects of the novel coronavirus disease 2019 (COVID-19) in pregnancy
remain relatively unknown. We present a case of second trimester pregnancy with …

Background Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to
be plagued by assay costs and supply chain shortages. In response, we developed …

Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing
COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR …

Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…

Background COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2.
It is widely recognized as a respiratory pathogen, but neurologic complications can be …

The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …

Rationale & Objective Acute kidney injury (AKI) is common in patients with coronavirus
disease 2019 (COVID-19) and associated with poor outcomes. Urinary biomarkers have been …

Rationale & Objective Patients hospitalized with COVID-19 are at increased risk for major
adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE in …